FindTrial
Sign In

A STUDY TO EVALUATE INCIDENCE OF RADIATION INDUCED PNEUMONITIS IN LUNG CANCER

A PROSPECTIVE STUDY TO EVALUATE THE RADIOLOGICAL AND CLINICAL INCIDENCE OF RADIATION INDUCED PNEUMONITIS IN LUNG CANCER PATIENTS TREATED WITH (CHEMO)RADIOTHERAPY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2012/08/002870
Enrollment
68
Registered
2012-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PATIENTS HAVING LUNG CANCER SHALL BE ACCRUED AFTER COMPLETION OF (CHEMO)RADIOTHERAPY

Interventions

None listed

Sponsors

TATA MEMORIAL HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)All patients of lung cancer treated with curative doses of Radiotherapy/Chemo-radiotherapy. 2) Patients who are willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1)Patients who have received reirradiation to lung. 2)All patients for palliative radiotherapy doses.

Design outcomes

Primary

MeasureTime frame
Appearance of symptoms of radiation pneumonitis (grade 2 or more) in radically treated lung cancer patients. Timepoint: At every three monthly follow up for a period of one year—

Secondary

MeasureTime frame
Appearance of radiological changes of RIP within a time interval of one year and their correlation with the dose distribution as well as the various factors modifying them.Timepoint: At every three monthly follow up for a period of one year—

Countries

India

Contacts

Public ContactDR J P AGARWAL

TATA MEMORIAL HOSPITAL

drsayandas28@gmail.com8879323102

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026